Viewing Study NCT00739232


Ignite Creation Date: 2025-12-24 @ 9:32 PM
Ignite Modification Date: 2025-12-29 @ 2:39 PM
Study NCT ID: NCT00739232
Status: COMPLETED
Last Update Posted: 2009-08-03
First Post: 2008-08-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Single Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HSD-016
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module